Intuitive Surgical (NASDAQ:ISRG) Director Craig Barratt Sells 1,150 Shares of Company Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Craig Barratt sold 1,150 shares of the firm’s stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $460.00, for a total transaction of $529,000.00. Following the sale, the director owned 1,150 shares in the company, valued at approximately $529,000. The trade was a 50.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Stock Down 3.9%

ISRG traded down $19.00 during trading on Thursday, hitting $463.10. The company had a trading volume of 2,238,358 shares, compared to its average volume of 2,444,045. The company has a market capitalization of $160.53 billion, a PE ratio of 56.00, a PEG ratio of 3.04 and a beta of 1.45. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88. The firm’s 50-day moving average price is $406.25 and its 200 day moving average price is $432.60.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company’s revenue was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.40 EPS. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current year.

Institutional Trading of Intuitive Surgical

Institutional investors have recently bought and sold shares of the company. Riverbridge Partners LLC acquired a new position in shares of Intuitive Surgical during the third quarter worth about $30,557,000. Silver Grove Financial Group Inc. raised its holdings in shares of Intuitive Surgical by 40.9% during the 3rd quarter. Silver Grove Financial Group Inc. now owns 389 shares of the medical equipment provider’s stock valued at $158,000 after buying an additional 113 shares during the period. Inspire Trust Co. N.A. acquired a new position in Intuitive Surgical during the 3rd quarter worth approximately $5,693,000. Bahl & Gaynor LLC boosted its holdings in Intuitive Surgical by 2.1% in the 3rd quarter. Bahl & Gaynor LLC now owns 8,419 shares of the medical equipment provider’s stock worth $3,423,000 after acquiring an additional 175 shares during the period. Finally, Northbridge Financial Group LLC boosted its holdings in Intuitive Surgical by 5.4% in the 3rd quarter. Northbridge Financial Group LLC now owns 2,755 shares of the medical equipment provider’s stock worth $1,115,000 after acquiring an additional 141 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Mizuho dropped their price target on Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating for the company in a research note on Wednesday, October 21st. Truist Financial cut their price target on shares of Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a report on Thursday, July 16th. Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 22nd. TD Cowen restated a “buy” rating and issued a $485.00 target price on shares of Intuitive Surgical in a research note on Monday, October 19th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $493.54.

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.